DISPLASIA ARRITMOGENICA DEL VENTRICULO DERECHO PDF

Se ha realizado tras consultar con profesionales de la salud y pacientes afectados por la enfermedad. Los latidos ventriculares prematuros no son peligrosos por si mismos y son relativamente frecuentes en personas sanas. Las personas con latidos ventriculares prematuros pueden sentir palpitaciones, notar latidos cardiacos fuera de su ritmo, o "vuelcos en el pecho". En ocasiones, puede ocurrir un error de deletreo en el proceso de copiado.

Author:Mem Kagore
Country:Luxembourg
Language:English (Spanish)
Genre:Personal Growth
Published (Last):16 January 2014
Pages:428
PDF File Size:4.58 Mb
ePub File Size:17.80 Mb
ISBN:952-4-22148-704-6
Downloads:88190
Price:Free* [*Free Regsitration Required]
Uploader:Dora



Overland Park, KS No obstante es frecuente la existencia de casos aislados. La mayor parte del miocardio del VD puede llegar a ser reemplazado por grasa 4,5. El septum suele ser respetado hasta llegar a estadios avanzados de la enfermedad. En algunos casos se observan placas de fibrosis. Es importante tener en cuenta que las alteraciones descriptas son inusuales en las formas leves.

Es importante tener en cuenta que un angiograma negativo no descarta MAVD. La enfermedad es progresiva y el VD puede verse afectado en forma difusa con el progreso de la misma. Por ello, el manejo de pacientes con MAVD es individual y basado en la experiencia de cada centro.

El tratamiento se dirige fundamentalmente al control de arritmias ventriculares malignas. Desfibrilador implantable. Este procedimiento se utiliza en casos seleccionados para aislar completamente la pared ventricular derecha. Algunos ya han comenzado. It is characterized pathologically by progressive fibrofatty replacement of the right ventricular myocardium and clinically by malignant ventricular arrhythmias.

Although it was considered an uncommon disease, it has been increasingly reported as cause of sudden arrhythmic death in young and otherwise healthy individuals. The etiology remains partially unknown although an autosomal dominant genetic predisposition was demonstrated. Non-familial and familial forms of the disease have been reported in the literature. The clinical manifestations varied from asymptomatic patients with an episode of sudden cardiac death as first symptom to chronically symptomatic patients with right or biventricular failure.

Major and minor criteria have been proposed for a positive diagnosis, which is very useful in the clinical practice. Common symptoms include exercise-induced palpitations, fatigue, dizziness, atypical chest pain and near-syncope or syncope.

The remaining patients can show signs of right ventricular failure. Frequently, the chest X-ray is normal. A common finding is T -wave inversion in V1 -V3, and sometimes through V6. The two-dimensional echocardiography is a very useful diagnostic test. Findings reported included right ventricular enlargement or multiple outpouchings and dyskinetic areas, mainly in the apical region or inferobasal wall.

Structural abnormalities of the moderator band, isolated dilatation of the right ventricular outflow tract, and travecular disarrangement have also been published. The left-ventricle is less frequently involved. In severe cases, tricuspid valve regurgitation can be found. Mitral valve prolapse is sometimes observed. The MRI shows excellent delineation of fat, which provides brighter signal and outline the subepicardial fat infiltration characteristic of this disease.

The CT scan features are a localized or diffuse involvement and dilatation of right ventricle, thinning of the right ventricular wall and hypokinesis.

The right ventricular cine-angiography is the gold standard for the diagnosis of the disease. It is also observed increased end-diastolic volume, slow evacuation of dye along the inferior wall, in fissures and aneurysms and in poorly contractile areas, and tricuspid valve prolapse associated with mild tricuspid insufficiency.

The endomyocardial biopsy may be helpful to confirm the diagnosis. The electrophysiological study with programmed ventricular stimulation is performed to induce ventricular tachycardia, define its morphologic characteristics and precise the region of origin in the right ventricle. It is very useful to evaluate the efficacy of antiarrhythmic drug treatment and implantable cardioverter defibrillator therapy. At present, there is limited information about clinical outcome of affected patients with overt disease, and even less on asymptomatic affected individuals.

The goal of the therapy is to prevent recurrent malignant ventricular arrhythmias. Although there are no precise guidelines to determine which are the patients who need to be treated and the best therapeutic approach, pharmacological treatment guided by programmed ventricular stimulation is considered the first step in patients with well-tolerated ventricular tachycardia.

Class I, class III antiarrhythmic drugs and betablockers, alone or combined, are the first and most frequently used therapy. The implantable cardioverter defibrillator is being increasingly used in the treatment of ventricular tachycardia and ventricular fibrillation.

In patients with frequent or incessant ventricular tachycardia or those who developed important side effects during drug therapy, radiofrequency ablation is the treatment of choice.

Cardiac surgery and transplant are rarely indicated. Arch Mal Coeur ; J Cardiovasc Electrophysiol ; Circulation ; Circulation ; 5: Can J Cardiol ; 8: Pinamonti B, Miani D, Sinagra G y col: Familial right ventricular dysplasia with biventricular involvement and inflammatory infiltration. Heart ; Fontaine G, Fontaliran F: Arrhythmogenic right ventricular dysplasia masquerading as dilated cardiomyopathy. Am J Cardiol ; Fontaine G, Fontaliran F: About the histology of arrhythmogenic right ventricular dysplasia.

N Engl J Med ; Valente M, Calabrese F, Thiene G y col: In vivo evidence of apoptosis in arrhythmogenic right ventricular cardiomyopathy. Am J Pathol ; Am Heart J ; Eur Heart J ; 10 suppl D : Blomstrom-Lundqvist C, Enestrom S, Edvardsson N y col: Arrhythmogenic right ventricular dysplasia presenting with ventricular tachycardia in a father and a son.

Clin Cardiol ; Nava A, Theine G, Canciani B y col: Familial occurrence of right ventricular dysplasia: a study involving nine families. J Am Coll Cardiol ; Am J Med Genet ; Coonar AS, Protonotarios N, Tsatsopoulou A y col: Gene for arrhythmogenic right ventricular cardiomyopathy with diffuse nonepidermolytic palmo -plantar keratoderma and wolly hair Naxos Disease maps to 17q Hum Mol Genet ; 3: Genomics ; Hum Mol Genet ; 4: Ahman F, Li D, Karibe A y col: Localization of a gene responsible for arrhythmogenic right ventricular dysplasia to chromosome 3p Li D, Ahmad F, Gardner MJ y col: The locus of a novel gene responsible for arrhythmogenic right ventricular dysplasia characterized by early onest and high penetrance maps to chromosome 10p12 Am J Hum Genet ; Br Heart J ; Corrado D, Basso C, Thiene G y col: Arrhythmogenic right ventricular cardiomyopathy: diagnosis, prognosis, and treatment.

Fontaine G, Frank R, Tonet JL y col: Arrhythmogenic right ventricular dysplasia: a clinical model for the study of chronic ventricular tachycardia. Jpn Circ ; Arch Mal Coeur Viass ; Scognamiglio R, Fasoli G, Nava A y col: Relevance of subtle echocardiographic findings in the early diagnosis of the concealed form of right ventricular dysplasia.

Eur Heart J ; 10 suppl D : 27 Clinical forms and main differential diagnoses Editorial. Am J Roentgenol ; Klersy C, Raisaro JA, Salerno C y col: Arrhythmogenic right and left ventricular disease: evaluation by computed tomography and nuclear magnetic resonance imaging. Eur Heart J ; 10 suppl D : 33 Daliento L, Rizzoli G, Thiene G y col: Diagnostic accuracy of right ventriculography in arrhythmogenic right ventricular cardiomyopathy.

Leclercq JF, Coumel P: Characteristics, prognosis and treatment of ventricular arrhythmias and right ventricular dysplasia. Eur Heart J ; 10 Suppl D : 61 Definition and mechanism of sudden death. Malvern PA, Williams Wilkins, , pp Girard F, Fontaine G, Fontaliran F y col: Catastrophic global heart failure in a case of non-arrhythmogenic right ventricular dysplasia. Heart Vessels ; Wichter T, Borggrefe M, Hoverkamp W y col: Efficacy of antiarrhythmic drugs in patients with arrhythmogenic right ventricular disease.

Results in patients with inducible and noninducible ventricular tachycardia. Guiraudon GM, Klein GJ, Gulamhusein SS y col: Total disconnection of the right ventricular free wall: surgical treatment of right ventricular tachycardia associated with right ventricular dysplasia.

Reservados todos los derechos. Documentos relacionados.

PORQUE TARDA O PLENO AVIVAMENTO PDF

Displasia arritmogénica del ventrículo derecho. Electrocardiografía. Caso clínico

.

TONY CLINK THE LAYGUIDE PDF

Displasia arritmogénica

.

D.L.223 06 PDF

Displasia arritmogénica del ventrículo derecho

.

Related Articles